No Data
Sudden Movement Spotlight | Biomedical Class B shares rose in the afternoon, LKYG-B up 30%, institutions bullish on sector further recovery space
Biomedical Class B shares rose in the afternoon, as of the time of publication, Lai Kai Medicine-B rose by 27.88%, to 7.89 Hong Kong dollars; YimingAngke-B rose by 17.91%, to 5.86 Hong Kong dollars; Yasheng Medicine-B rose by 5.74%, to 46.95 Hong Kong dollars.
Cryofocus Medtech's Subsidiary to Collaborate on Research, Development of Cryoballoon Ablation for Lung Cancer
Kangrun Biotech-B (06922.HK): Signed a research cooperation agreement with the Guangzhou National Laboratory and the First Affiliated Hospital of Guangzhou Medical University.
Gelonghui, October 16th - Kangrun Biotech-B (06922.HK) announced that its wholly owned subsidiary, Ningbo Shengjie Kang Biotechnology Co., Ltd. ("Ningbo Shengjie Kang"), will participate in and manage a research project approved by the Guangzhou National Laboratory in collaboration with the First Affiliated Hospital of Guangzhou Medical University. Ningbo Shengjie Kang, the Guangzhou National Laboratory, and the First Affiliated Hospital of Guangzhou Medical University recently signed a research cooperation agreement ("Research Cooperation Agreement") regarding the above-mentioned project. The Guangzhou National Laboratory is a new research institution in the field of respiratory system diseases and prevention, and is a core technology force in the field of respiratory system diseases. Guangzhou Medical
CRYOFOCUS-B: INTERIM REPORT 2024
Hong Kong stock opportunity tracking | Hong Kong Exchange may suspend trading all day today; "Carrier-level" broker is coming! GTJA and Haitong Sec will merge and reorganize.
Nio Inc: In the second quarter, revenue increased by 98.9% year-on-year, and the loss narrowed significantly by 16.7% year-on-year; Greentown China's sales in the first 8 months exceeded 160 billion yuan; SHK PPT's profit dropped by approximately 20% in the last fiscal year.
Cryofocus Medtech Converts Over 29 Million Unlisted Shares to H Shares
